Suresh R Parikh, MD in Cheektowaga, NY - General Practice

Suresh R Parikh, MD is a General Practice physician based in Cheektowaga, New York. Suresh R Parikh is licensed to practice in New York (license number 145098) and his current practice location is 2605 Harlem Rd, Cheektowaga, New York. He can be reached at his office (for appointments etc.) via phone at (716) 891-2400.

NPI number for Suresh R Parikh is 1578779252 and his current mailing address is 24 Deerchase Rd, W Seneca, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1578779252.

Contact Information

	Suresh R Parikh, MD
	2605 Harlem Rd, Cheektowaga, NY 14225-4018
	(716) 891-2400
	Not Available

Physician's Profile

Full Name	Suresh R Parikh
Gender	Male
Speciality	General Practice
Location	2605 Harlem Rd, Cheektowaga, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1578779252
Provider Enumeration Date: 05/16/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Suresh R Parikh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578779252	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	145098 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Suresh R Parikh is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Suresh R Parikh, MD 24 Deerchase Rd, W Seneca, NY 14224-1244 Ph: (716) 826-5754	Suresh R Parikh, MD 2605 Harlem Rd, Cheektowaga, NY 14225-4018 Ph: (716) 891-2400

News Archive

Tick-borne disease identified as emerging threat

Five years ago, large numbers of farmers in central China began falling victim to an mysterious disease marked by high fever, gastrointestinal disorder and an appalling mortality rate - as high as 30 percent in initial reports. Investigators from the Chinese Center for Disease Control and Prevention hurried to the scene of the outbreak. On the basis of DNA evidence, they quickly concluded that it had been caused by human granulocytic anaplasmosis, a bacteria transmitted by tick bites.

Biopharmaceuticals industry, a rapidly growing sector within the pharmaceuticals industry

Global manufacturing of biopharmaceuticals has increased significantly over the last decade due to a number of reasons. Biopharmaceuticals offer several advantages such as highly effective and potent action, fewer side effects and the potential to actually cure diseases rather than merely treat the symptoms.

Pioneer calls on electrophysiologists to reexamine substrate mapping for deadly heart arrhythmia

A pioneer in developing life-saving therapies for a deadly heart arrhythmia has called on electrophysiologists to reexamine a widely used technique to guide the treatment of the faulty electrical impulses responsible for these abnormal heartbeats.

BioTel system to test methods of improving cardiac arrest

UT Southwestern Medical Center is among 10 institutions selected to oversee innovative clinical trials designed to test life-saving interventions for critical trauma and sudden cardiac arrest.

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

You can't see it, hear it or smell it, and it's constantly changing: but despite that, Australia's nuclear scientists have figured out how to more accurately measure the unit of activity for radionuclides, the Becquerel (Bq).

Suresh R Parikh, MD - General Practice in Cheektowaga, NY